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Voltage-gated K+ (Kv) channels play important roles in regulating neuronal excitability.
Kv channels comprise four principal α subunits, and transmembrane and/or cytoplasmic
auxiliary subunits that modify diverse aspects of channel function. AMIGO-1, which
mediates homophilic cell adhesion underlying neurite outgrowth and fasciculation during
development, has recently been shown to be an auxiliary subunit of adult brain
Kv2.1-containing Kv channels. We show that AMIGO-1 is extensively colocalized with
both Kv2.1 and its paralog Kv2.2 in brain neurons across diverse mammals, and that in
adult brain, there is no apparent population of AMIGO-1 outside of that colocalized with
these Kv2 α subunits. AMIGO-1 is coclustered with Kv2 α subunits at specific plasma
membrane (PM) sites associated with hypolemmal subsurface cisternae at neuronal
ER:PM junctions. This distinct PM clustering of AMIGO-1 is not observed in brain neurons
of mice lacking Kv2 α subunit expression. Moreover, in heterologous cells, coexpression
of either Kv2.1 or Kv2.2 is sufficient to drive clustering of the otherwise uniformly
expressed AMIGO-1. Kv2 α subunit coexpression also increases biosynthetic intracellular
trafficking and PM expression of AMIGO-1 in heterologous cells, and analyses of Kv2.1
and Kv2.2 knockout mice show selective loss of AMIGO-1 expression and localization
in neurons lacking the respective Kv2 α subunit. Together, these data suggest that
in mammalian brain neurons, AMIGO-1 is exclusively associated with Kv2 α subunits,
and that Kv2 α subunits are obligatory in determining the correct pattern of AMIGO-1
expression, PM trafficking and clustering.
Keywords: ion channel, auxiliary subunit, brain, immunohistochemistry, cell adhesion molecule
INTRODUCTION
Mammalian voltage-gated potassium (Kv) channels function as macromolecular assemblies of four
voltage-sensing and pore-forming principal or α subunits (Trimmer, 2015). Substantial structural
and functional heterogeneity in native Kv channels is generated from the combinatorial assembly
of two dozen α subunit genes into homo- and hetero- tetrameric complexes, and their subsequent
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posttranslational modification (Trimmer, 2015). This already
substantial diversity is further enhanced by coassembly with a
large repertoire of cytoplasmic and/or transmembrane auxiliary
subunits (Li et al., 2006; Pongs and Schwarz, 2010; Vacher
and Trimmer, 2011). Kv channel auxiliary subunits impact Kv
channel activity indirectly through effects on protein assembly
and folding, regulation of biosynthetic intracellular trafficking,
clustering at specific plasma membrane (PM) sites, and by
influencing rates of endocytic recycling and degradation (Li
et al., 2006; Pongs and Schwarz, 2010; Vacher and Trimmer,
2011). They can also exert profound effects on the function of
Kv channels by impacting diverse aspects of channel gating (Li
et al., 2006; Pongs and Schwarz, 2010; Vacher and Trimmer,
2011). This diversity provides opportunities for development of
drugs and biologicals that impact channel function by modifying
the interaction of auxiliary subunits with Kv channel complexes
(Zhang et al., 2004; Lundby et al., 2010; Witzel et al., 2012; Ohya
et al., 2016). Certain ion channel auxiliary subunits have been
shown to exhibit functions independent of their role as auxiliary
subunits, most notably the β subunits of voltage-gated sodium
channels that function as cell adhesion molecules (Kruger and
Isom, 2016).
Kv channels formed by the Kv2 α subunits Kv2.1 and
Kv2.2 are highly expressed in mammalian brain neurons,
where they exhibit robust clustering on cell bodies, proximal
dendrites and the axon initial segment (Trimmer, 2015). Kv2.1
is widely expressed in mammalian brain where it is responsible
for the majority of the delayed rectifier current in many
neurons (Murakoshi and Trimmer, 1999; Du et al., 2000; Malin
and Nerbonne, 2002; Bishop et al., 2015). Kv2.1 is highly
phosphorylated (Misonou et al., 2006) and localized to PM
clusters (Trimmer, 1991; Scannevin et al., 1996; Du et al., 1998;
Mandikian et al., 2014; Bishop et al., 2015) that are found at
endoplasmic reticulum: PM junctions (i.e., ER:PM junctions)
(Du et al., 1998; Antonucci et al., 2001; Mandikian et al., 2014;
Bishop et al., 2015; Fox et al., 2015). Kv2.1 phosphorylation
is found primarily on the large cytoplasmic C-terminal tail
(Trimmer andMisonou, 2015), which also contains a short motif
required for clustering at ER: PM junctions (Lim et al., 2000; Fox
et al., 2015). Kv2.2 differs from Kv2.1 in having a more restricted
cellular expression in brain (Hwang et al., 1992), less extensive
phosphorylation (Bishop et al., 2015; Trimmer and Misonou,
2015), and more constitutive clustering (Bishop et al., 2015)
compared to Kv2.1. Kv2.1 and Kv2.2 can form heterotetrameric
channels in coexpressing neurons (Kihira et al., 2010; Bishop
et al., 2015), although certain brain neurons express high levels
of Kv2.1 or Kv2.2 but not both (Hermanstyne et al., 2010; Bishop
et al., 2015).
The single pass type I transmembrane protein AMIGO-1,
which was originally discovered in a screen for genes induced
by the neurite outgrowth promoting protein amphoterin (Kuja-
Panula et al., 2003), was recently found to associate and
colocalize with Kv2.1 in adult brain (Peltola et al., 2011).
Unlike Kv2.1 and Kv2.2, AMIGO-1 has an extensive extracellular
domain, which includes leucine-rich repeat and immunoglobulin
domains. During development, AMIGO-1 acts as a homophilic
cell adhesion molecule to promote neurite outgrowth in neurons
(Kuja-Panula et al., 2003; Chen et al., 2012). AMIGO-1
colocalizes with Kv2.1 in large PM clusters in brain neurons both
in vivo and in vitro, and when coexpressed in HEK293 cells
(Peltola et al., 2011). Coexpression with AMIGO-1 produces a
hyperpolarizing shift in the voltage-dependent gating of Kv2.1
(Peltola et al., 2011), and mice lacking AMIGO-1 expression
have reduced Kv2.1 expression (Peltola et al., 2016), consistent
with a role for AMIGO-1 as a bona fide auxiliary subunit of
Kv2.1-containing channels. However, the full extent of AMIGO-
1 association with the Kv2.1 and Kv2.2 α subunits in brain, and
the role of Kv2 α subunits in determining the expression and
localization of AMIGO-1, has not been investigated. Here, we use
newly developed and KO-validated anti-AMIGO-1 antibodies
(Abs) to define the expression and colocalization of AMIGO-1
with Kv2.1 and Kv2.2 in adult brain. We also analyze the impact
of the Kv2 α subunits on expression and localization of AMIGO-
1 in studies employing single and double Kv2.1 and Kv2.2 KO
mice, and heterologous cells expressing WT and mutant Kv2 α
subunits. These studies reveal an important role for Kv2 channels
in supporting the expression and localization of AMIGO-1 in
adult brain neurons.
MATERIALS AND METHODS
Unless otherwise stated, all chemicals were from Sigma-Aldrich.
Antibodies
Antibodies used here are listed in Table 1.
Generation of Novel Monoclonal and
Polyclonal Antibodies
A hybridoma producing the L98/12 (IgG1) monoclonal
antibody (mAb) was generated from a mouse immunized
with extracellular N-terminus of AMIGO-1 using standard
methods (Trimmer et al., 1985; Bekele-Arcuri et al., 1996). The
immunogen was a Strep2-tagged fusion protein comprising the
extracellular domain (a.a. 28–370) of AMIGO-1 produced in
HEK293 cells (Kajander et al., 2011). The anti-AMIGO-1 rabbit
polyclonal antibody (pAb) was generated at Pocono Rabbit Farm
and Laboratory (Canadensis, PA) against amino acids 394–492
(cytoplasmic C-terminus) of mouse AMIGO-1, exhibiting 100%
amino acid identity with rat and human AMIGO-1, and used
previously to generate a chicken pAb (Peltola et al., 2011).
Anti-AMIGO-1 polyclonal Abs were affinity purified from serum
on nitrocellulose strips containing the immunogen following the
method of Olmsted (Olmsted, 1981).
Antibody Characterization
Table 1 contains a list of all Abs used in this study.
The anti-AMIGO-1 affinity-purified rabbit pAb “AMIGO-1”
(Trimmer Lab, RRID:AB_2571515) was validated by
immunoblot against wild-type (WT) and AMIGO-1-KO
mouse brain samples, by immunohistochemistry against WT
and AMIGO-1-KO mouse brain sections (see below), and does
not detect other AMIGO isoforms by immunocytochemistry
and immunoblotting using samples from heterologous cells
expressing either AMIGO-1, AMIGO-2, or AMIGO-3.
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TABLE 1 | Antibodies used in this study.
Antibody name Species/isotype/immunogen Manufacturer information Concentration used
AMIGO-1, anti-AMIGO-1 rabbit
pAb
Raised against a.a. 394-492 of mouse
AMIGO-1 (cytoplasmic C-terminus)
Trimmer Lab. Rabbit 28330
RRID:AB_2571515
1:500 dilution of Affinity Purified pAb,
concentration unknown
L86/33, anti-AMIGO-1 mouse
IgG2a mAb
Raised against a.a. 394-492 of mouse
AMIGO-1 (cytoplasmic C-terminus)
Trimmer lab. NeuroMab Cat# 73-317,
RRID:AB_2315798
1:5 dilution of Tissue Culture
Supernatant, concentration unknown
L86A/37, anti-AMIGO-1 mouse
IgG2b mAb
Raised against a.a. 394-492 of mouse
AMIGO-1 (cytoplasmic C-terminus)
Trimmer lab. NeuroMab Cat# 75-329,
RRID:AB_2315801
1:5 dilution of Tissue Culture
Supernatant, concentration unknown
L98/12, anti-AMIGO-1 mAb Mouse IgG1 mAb, Raised against a.a.
28-370 of mouse AMIGO-1 (extracellular
N-terminus)
Trimmer lab. RRID:AB_2571516 1:5 dilution of Tissue Culture
Supernatant, concentration unknown
K89/34, anti-Kv2.1 mouse IgG1
mAb
Raised against a.a. 837-853 of rat Kv2.1 Trimmer lab. NeuroMab Cat# 73-014
RRID:AB_10672253
10µg/mL Purified mAb
K89/34R, anti-Kv2.1
recombinant mouse IgG2a mAb
Raised against a.a. 837-853 of rat Kv2.1 Trimmer lab. Recombinant mouse mAb
expressed in COS-1 cells.
RRID:AB_2315768
1:2 dilution of Tissue Culture
Supernatant, concentration unknown
N372B/1, anti-Kv2.2 mouse
IgG1 mAb
Raised against a.a. 717-907 of rat Kv2.2.
Binds within a.a. 764-907. Species
reactivity with mouse, rat, ferret, macaque
and human
NeuroMab. Cat# 73-369,
RRID:AB_2315869
1:5 dilution of Tissue Culture
Supernatant, concentration unknown
N372B/60, anti-Kv2.2 mouse
IgG2b mAb
Raised against a.a. 717-907 of rat Kv2.2.
Binds within a.a. 764-907. Species
reactivity with mouse and rat
NeuroMab. Cat# 73-360,
RRID:AB_2315867
1:5 dilution of Tissue Culture
Supernatant, concentration unknown
25B6, anti-Ctip2 rat IgG2a mAb Raised against aa 1-150 of human Ctip2 Abcam. Cat# ab18465,
RRID:AB_2064130
0.5µg/mL Purified mAb
M-222, anti-Cux1 rabbit pAb Rabbit pAb, Raised against aa 1111-1332
of mouse Cux1/CDP
Santa Cruz Biotechnology. Cat#
sc-13024, RRID:AB_2261231
0.4µg/mL Purified pAb
SATBA4B10, anti-Satb2 mouse
IgG1 mAb
Raised against recombinant fragment
corresponding to C-terminus of human
SATB2
Abcam. Cat# ab51502, RRID:AB_882455 0.1µg/mL Purified mAb
N52A/42, anti-Mortalin/Grp75
mouse IgG1 mAb
Off target mAb from anti-Salm2 project NeuroMab. Cat# 73-127,
RRID:AB_10674108
1:20 dilution of Tissue Culture
Supernatant, concentration unknown
Details of the polyclonal (pAb) and monoclonal (mAb) Abs used in this study.
The anti-AMIGO-1 mouse mAbs L86/33 (NeuroMab Cat#
73-317, RRID:AB_2315798) and L86A/37 (NeuroMab Cat#
73-329, RRID:AB_2315765) were validated by immunoblot
against WT and AMIGO-1-KO brain samples, and by
immunohistochemistry against WT and AMIGO-1-KO mouse
brain sections (see below). These mAbs do not detect other
AMIGO isoforms on immunoblots of cell lysates prepared from
heterologous cells expressing AMIGO-1, AMIGO-2, or AMIGO-
3. The anti-AMIGO-1 mouse mAb L98/12 (Trimmer Lab,
RRID:AB_2571516) was validated by immunohistochemistry
against WT and AMIGO-1-KO mouse brain sections (see
below), and against heterologous cells expressing AMIGO-1 and
untransfected cells by ELISA and immunocytochemistry.
The anti-Kv2.1 K89/34 mouse mAb (NeuroMab Cat#
73-014, RRID:AB_10672253) was validated by immunoblot
against WT and Kv2.1-KO mouse brain samples, and by
immunohistochemistry against WT and Kv2.1-KO mouse brain
sections, as described (Mandikian et al., 2014; Bishop et al.,
2015). The anti-Kv2.1 K89/34R recombinant mouse mAb
(Trimmer Lab, RRID:AB_2315768), which is the recombinant
version of K89/34 with the IgG1 heavy chain constant region
replaced with that of the IgG2a subclass (Mandikian et al.,
2014) was validated by immunohistochemistry against WT and
Kv2.1-KO mouse brain sections, as described (Mandikian et al.,
2014).
The anti-Kv2.2 mouse mAbs N372B/1 (NeuroMab Cat#
73-369, RRID:AB_2315869) and N372B/60 (NeuroMab Cat#
73-360, RRID:AB_2315867) were validated by immunoblot
against WT and Kv2.2-KO mouse brain samples, and by
immunohistochemistry against WT and Kv2.2-KO mouse brain
sections, as described (Bishop et al., 2015).
The anti-Ctip2 rat mAb 25B6 (Abcam Cat# ab18465,
RRID:AB_2064130) was made against a fusion protein
containing a.a. 1–150 of human Ctip2 and was validated
by the manufacturer for use in immunohistochemistry,
immunocytochemistry, immunoblot, immunoprecipitation, and
chromatin immunoprecipitation analyses.
The anti-Cux1 rabbit pAb M-222 (Santa Cruz Biotechnology
Cat# sc-13024, RRID:AB_2261231) was made against C-terminal
a.a. 1,111–1,332 of mouse CDP (Cux1) and was validated
by the manufacturer for use in immunohistochemistry,
immunocytochemistry, immunoblot, immunoprecipitation, and
chromatin immunoprecipitation analyses.
The anti-Satb2 mouse mAb SATBA4B10 (Abcam Cat#
ab51502, RRID:AB_882455) was made against a recombinant
C-terminal fragment of human Satb2 and was validated
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by the manufacturer for use in immunohistochemistry,
immunocytochemistry, immunoblot, immunoprecipitation and
chromatin immunoprecipitation analyses.
The anti-Mortalin/GRP75 mouse mAb N52A/42 (NeuroMab
Cat# 73-127, RRID:AB_10674108) was validated by LC-MS/MS
analysis of immunoprecipitation reactions performed against
rat brain extracts, and by immunoblot against HEK293 cells
expressing endogenous Mortalin/GRP75 using siRNA-mediated
knockdown (manufacturer’s specifications).
Animals
All animal use procedures involving rats and Kv2 KO mice were
performed in strict accordance with the Guide for the Care
and Use of Laboratory Animals of the U.S. National Institutes
of Health (NIH), and were approved by the University of
California Davis Institutional Animal Care and Use Committee.
Mice and rats were maintained under standard light–dark cycles
and allowed to feed and drink ad libitum. Kv2.1-KO mice
(RRID:IMSR_MGI:3806050) have been described previously
(Jacobson et al., 2007; Speca et al., 2014), and were generated
by breeding Kv2.1+/− mice backcrossed onto a C57/BL6J
background (RRID:IMSR_JAX:000664) such that all experiments
with Kv2.1-KO mice used WT littermates as controls. Kv2.2-KO
mice were obtained from Drs. Tracey Hermanstyne and Jeanne
Nerbonne, and have been described previously (Hermanstyne
et al., 2010, 2013). All Kv2.2−/− mice used here were obtained
from homozygotic crosses. Kv2.1 and Kv2.2 double-KO (Kv2
dKO) mice (Kv2.1−/−/Kv2.2−/−) were generated by breeding
Kv2.1+/− mice with Kv2.2−/− mice. Both male and female mice
were used, all over 10 weeks old. Sprague-Dawley rats (Female
200-300 g, Charles River) were >15 week old females.
Preparation of Brain Sections
For preparation of brain sections, rats and mice were deeply
anesthetized with 60 mg/kg sodium pentobarbital and
transcardially perfused with ≈5mL (mouse) or ≈20mL
(rat) phosphate-buffered saline (PBS; 150mM NaCl, 10mM
sodium phosphate buffer, pH7.4) containing 10 U/mL heparin,
followed by ≈30mL (mouse) or ≈150mL (rat) ice-cold 4%
formaldehyde (freshly prepared from paraformaldehyde) in
0.1M sodium phosphate buffer, pH 7.4 (0.1M PB). The brains
were removed and cryoprotected for 24 h in 10% sucrose 0.1M
PB, and then for 24–48 h in 30% sucrose in 0.1M PB. Perfusion-
fixed brains from age- and sex-matched WT and AMIGO-1 KO
mice (Peltola et al., 2016) were prepared in strict accordance
with the Guide for the Care and Use of Laboratory Animals of
the U.S. National Institutes of Health (NIH), and were approved
by the Helsinki University Institutional Animal Care and Use
Committee. Perfusion-fixed and cryoprotected ferret brains
were gifts from the laboratory of our late colleague Dr. Barbara
Chapman. Fresh-frozen macaque samples were a gift from the
laboratory of our late colleague Dr. Edward G. Jones. Fresh-
frozen human brain samples (49.5-year-old Caucasian male, 5-h
post-mortem interval) were obtained from the U.S. National
Institute of Child Health and Human Development (NICHD)
Brain and Tissue Bank for Developmental Disorders (NICHD
contract HHSN275200900011C, ref. NO1-HD-9–0011). Samples
from the visual cortex of human and macaque were thawed
in the same fixative used for perfusions, fixed for 45min at
4◦C, and cryoprotected as for perfusion fixed brains. Following
cryoprotection, all samples were frozen, and 30µm sections were
generated using a freezing stage sliding microtome (Richard
Allen Scientific HM 450). Sections were collected in 0.1M PB
and processed for immunohistochemistry.
Multiplex Immunofluorescence Labeling of
Brain Sections
Multiplex immunofluorescence labeling was performed
essentially as described previously (Manning et al., 2012; Bishop
et al., 2015). In brief, free-floating sections were incubated in 10%
goat serum in 0.1M PB containing 0.3% Triton X-100 (vehicle)
for 1 h and then incubated 3 h at room temperature (RT) in
vehicle containing different combinations of primary Abs, as
detailed in the respective figure legends. Following incubation,
sections were washed three times for 10min each in 0.1M PB,
and incubated for 1 h in vehicle containing affinity-purified
species and/or mouse IgG–subclass-specific goat secondary Abs
(Manning et al., 2012) conjugated to Alexa Fluors (Molecular
Probes/ThermoFisher). Sections were labeled with the DNA-
specific dye Hoechst 33258 during the secondary antibody
step. Following three 10min washes in 0.1M PB, sections were
mounted and dried onto gelatin-coated slides, treated with 0.05%
Sudan Black (EM Sciences) in 70% ethanol for 5min (Schnell
et al., 1999), extensively washed in water, and mounted with
Prolong Gold (Life Technologies/ThermoFisher).
Low-magnification images were acquired on a Zeiss
AxioObserver Z1 microscope using a 10 × /0.5 NA Fluar
objective and an AxioCam HRm digital camera, and
reconstructed as tiled mosaics using Axiovision 4.0 (Carl Zeiss
MicroImaging, RRID:S- ciRes_000111). High-magnification
images were acquired on a Zeiss AxioImager M2 microscope
using a 40× /0.8 NA plan-Apochromat oil-immersion objective,
or a 63 × /1.40 NA plan-Apochromat oil immersion objective,
and an AxioCam MRm digital camera. Optical sections were
acquired using an ApoTome 2 structured illumination system
(Carl Zeiss MicroImaging). Imaging and post processing was
performed in Axiovision (Carl Zeiss MicroImaging), ImageJ
(National Institutes of Health) and MATLAB (MathWorks).
Super-resolution light microscopy was performed on a Zeiss
Elyra system (SR-SIM) using a 100 × /1.4 NA plan-Apochromat
oil immersion objective and Z stacks were reconstructed with
Zen software (Carl Zeiss MicroImaging). Linear adjustments
to contrast and brightness were performed using Photoshop
(Adobe Systems) or ImageJ. All panels in a given figure were
imaged and treated identically, unless otherwise noted.
Electron Microscopic
Immunohistochemistry
All mouse handling and sample preparation procedures for
electron microscopy were done at the National Institute for
Physiological Sciences, Okazaki, Japan and were conducted
under regulatory guidelines of the institution. Adult mice
were anesthetized with pentobarbital and transcardially perfused
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with 100ml of ice-cold 4% formaldehyde (freshly prepared
from paraformaldehyde) in 15% saturated picric acid/0.05%
glutaraldehyde in 0.1M PB, pH 7.4. Brains were removed and
sectioned to 50µm using a vibratome (Leica model VT-1000).
Sections were incubated in a blocking solution containing 20%
normal goat serum in 50mM Tris (pH 7.6) plus 150mM NaCl
for 1 h. Sections were then incubated for 48 h at 4◦C with
purified anti-Kv2.1 K89/34 mouse mAb (diluted to 10µg/mL
in vehicle: 2% NGS in TBS) or anti-AMIGO-1 L86/33 mouse
mAb tissue culture supernatant (diluted 1:2 in vehicle). After
three washes in 25mM PB (pH 7.4) plus 150mM NaCl (25mM
PBS), sections were incubated overnight at 4◦C with an anti-
mouse secondary antibody conjugated to 1.4 nm gold particles
(Nanoprobes, 1:100 dilution). Sections were washed three times
in 25mMPBS and once in milliQ water. Thereafter, immunogold
particles were silver intensified using the HQ silver enhancement
kit (Nanoprobes). Silver intensified sections were treated with
1% osmium tetroxide, en bloc counterstained with uranyl acetate,
dehydrated and flat embedded in Durcupan resin (ACM Fluka,
Sigma-Aldrich). Ultrathin sections (70 nm) were collected on
formvar coated single-slot copper grids, counterstained briefly
with freshly prepared 1% lead citrate and analyzed using a Philips
transmission electron microscope (EM208S) equipped with a
MegaView III CCD camera (Olympus-SIS).
Heterologous Cell Culture and Transfection
HEK293 cells were maintained in Dulbecco’s modified Eagle’s
medium supplemented with 10% Fetal Clone III (HyClone),
1% penicillin/streptomycin, and 1X GlutaMAX (ThermoFisher).
HEK293 cells were split to 15% confluence then transiently
transfected 24 h later with the respective plasmids. These
included plasmids encoding rat Kv2.1 (Frech et al., 1989; Shi
et al., 1994) or the non-clustering rat Kv2.1 mutant S586A
(Lim et al., 2000), and/or rat Kv2.2 (Kihira et al., 2010), or
the non-clustering rat Kv2.2 mutant S605A (Bishop et al.,
2015), all in the mammalian expression vector pRBG4 (Lee
et al., 1991) and/or mouse AMIGO-1 in the mammalian
expression vector PC DNA6 V5 His Version A (Peltola et al.,
2011). Transfections were performed using LipofectAMINE
2000 (Invitrogen/ThermoFisher) transfection reagent following
the manufacturer’s protocol. HEK293 cells were transfected in
DMEM without supplements, then returned to regular growth
media 4 h after transfection. For live cell imaging experiments,
HEK293 cells were transiently transfected with the general ER
marker SEC61β-BFP, and DsRed-Kv2.1 and/or YFP-AMIGO-1
using the same approach. YFP-AMIGO-1 for live cell imaging
was generated via Gibson assembly of mouse AMIGO-1 into
the YFP-N1 vector (ClonTech) resulting in fusion of YFP to the
cytoplasmic C-terminus of full-length mouse AMIGO-1. DsRed-
Kv2.1 was generated via insertion of full-length rat Kv2.1 into
the DsRed-C1 vector (ClonTech) resulting in fusion of DsRed to
the N-terminus of full-length Kv2.1. The BFP-Sec61 beta plasmid
encoding SEC61β-BFP (Zurek et al., 2011) was a gift from Gia
Voeltz (Addgene plasmid # 49154). All plasmids were verified by
sequencing. HEK293 cells were used 40–48 h post-transfection.
Cells were grown in a humidified incubator at 37◦C and 5% CO2.
Immunofluorescence Labeling of HEK293
Cells
Immunofluorescence labeling was performed on permeabilized
(Shi et al., 1994; Cobb et al., 2015) or intact (Shi et al., 1996)
fixed cells essentially as described. Briefly, labeling of fixed and
permeabilized cells was performed on HEK293 cells grown on
poly-L-lysine coated glass coverslips, and fixed for 15min at 4◦C
in ice-cold fixation buffer containing 4% formaldehyde (prepared
fresh from paraformaldehyde), 4% sucrose, 0.1% Triton X-100 in
DPBS (137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.7mM
KH2PO4, pH 7.4) containing 1mM CaCl2 and 1mM MgCl2.
All subsequent steps were performed at RT. Cells were washed
3X for 10min each in PBS, blocked for 45min with Blotto (3%
(w/v) non-fat dry milk powder in TBS) with 0.1% Triton X-100,
then incubated in Blotto containing primary Abs for 1 h. For cell
surface labeling of intact HEK293 cells, cells were fixed for 25min
4◦C in the same fixative as above minus the Triton X-100. All
subsequent steps were performed at RT. Fixed cells were washed
3X for 10min each in PBS, blocked with Blotto without Triton
X-100 for 45min, incubated with anti-AMIGO-1 mouse mAb
L98/12 diluted in Blotto without Triton X-100 for 1 h, washed
3X for 10min each in PBS, then permeabilized for 30min with
Blotto containing 0.1% Triton X-100, followed by incubation
with anti-AMIGO-1 rabbit pAb and/or Kv2.1 and Kv2.2 mAbs
for 1 h. Primary Abs were detected with goat secondary Abs
against either the specific mouse IgG subclass of the mAbs,
or against rabbit IgG, conjugated to Alexa Fluors (Molecular
Probes/ThermoFisher). Cells were labeled with Hoechst 33258
during incubation with secondary Abs. Images were acquired
with an AxioCam MRm digital camera installed on a Zeiss
AxioImager M2 microscope, or with an AxioCam HRm digital
camera installed on a Zeiss AxioObserver Z1 microscope,
using a 63X/1.40 NA plan-Apochromat oil immersion objective
and an ApoTome coupled to Axiovision software (Carl Zeiss
MicroImaging).
Live Cell TIRF Imaging of HEK293 Cells
Total internal reflection fluorescence (TIRF) imaging was
performed at the MCB Imaging Facility at UC Davis. Live
transfected HEK293 cells were imaged in a physiological saline
solution (4.7mM KCl, 146mM NaCl, 2.5mM CaCl2, 0.6mM
MgSO4, 1.6mM NaHCO3. 0.15mM NaH2PO4, 20mM HEPES,
pH 7.4) containing 8mM glucose and 0.1mM ascorbic acid. Cells
were maintained at 37◦C during the course of imaging with a
heated stage and objective heater. Images were obtained with
an Andor iXon EMCCD camera installed on a TIRF/widefield
equipped Nikon Eclipse Ti microscope using a Nikon LUA4 laser
launch with 405, 488, 561, and 647 nm lasers and a 100X PlanApo
TIRF, 1.49 NA objective run with NIS Elements software (Nikon).
Images of SEC61β-BFP, YFP-AMIGO-1 and DsRed-Kv2.1 were
acquired at a constant exposure time in TIRF.
Image Analysis
All images were transferred to PhotoShop software (Adobe
Systems) or ImageJ (National Institutes of Health) as linear
8-bit TIF files. For clustering analyses in heterologous cells, an
n of four independent samples of at least 100 cells each was
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scored for having clustered or dispersed localization. For analysis
of clustering in heterologous HEK293 cells by coefficient of
variation, ImageJ was used to measure the mean and standard
deviation of the pixel intensity values of regions of interest (ROIs)
drawn around each cell, excluding the edge of the cell, from an
n of four independent samples of at least 14 cells each, imaged
with a 63X objective. For analysis of clustering by coefficient
of variation in brain sections, at least 25 cells per section
from three independent animals were analyzed. For AMIGO-
1 cell surface expression analysis, the mean pixel intensity
values of cell surface AMIGO-1 (mAb L98/12) immunolabeling
and total AMIGO-1 (AMIGO-1 rabbit pAb) immunolabeling
of ROIs drawn around each cell, excluding the edge of the
cell, were measured using ImageJ. The ratio of cell surface to
total AMIGO-1 immunolabeling was calculated and normalized
to the average ratio in cells expressing AMIGO-1 alone for
that independent sample. This analysis was performed in four
independent samples of at least an n = 67 cells total, imaged
with a 63X objective. All images were measured from Z stacks of
optical sections taken at equal exposure across all images within
an experiment. Representative images were taken with optimal
exposure time and the brightness and contrast linearly adjusted
to optimize display.
Analysis of colocalization between SEC61β-BFP, YFP-
AMIGO-1, and DsRed-Kv2.1 was performed in NIS elements.
A region of interest was drawn within each cell analyzed,
excluding the edge of the cell, and Pearson’s correlation
coefficients were collected. Quantification of ER:PM junction
size was performed in FIJI. Images (ND2 files) of BFP-SEC61β
collected in TIRF were imported directly into FIJI, background
subtracted using a rolling ball radius of 10 pixels, converted
into an 8 bit image, and automatically converted into a binary
mask using auto local thresholding. An ROI with identical
dimensions was drawn within each cell analyzed. The average
size of ER:PM junctions was quantified automatically using
the “analyze particles” function within FIJI. ER:PM junctions
smaller than 0.04 µm2 were excluded from this analysis.
These data sets were imported into GraphPad Prism software
for presentation and statistical analysis. Means are shown ±
standard deviation.
Proteinase K Digestion of HEK293 Cells
Proteinase K analysis of cell surface expression was performed
essentially as described (Zhou et al., 1998; Manganas and
Trimmer, 2000). Briefly, live transfected HEK293 cells were
washed once at 37◦C with DPBS with 1mM CaCl2 and 1mM
MgCl2, followed by 30min incubation at 37
◦C with 10mM
HEPES, 150mM NaCl, and 2mM CaCl2 (pH 7.4) with or
without 200µg/mL Proteinase K (Roche). The reaction was
quenched by adding ice-cold DPBS (without 1mM CaCl2 and
1mM MgCl2) containing 6mM phenylmethylsulfonyl fluoride
(PMSF) and 25mM EDTA. Cells were harvested with a cell
scraper, pelleted by centrifugation at 4◦C at 400 × g for
5min in a microcentrifuge, and resuspended in reducing SDS
sample buffer. Lysates were analyzed by immunoblot as described
below.
Preparation of Crude Mouse Brain
Homogenates
For preparation of crude brain homogenates, mice were
decapitated without anesthesia and brains were removed
and homogenized within a 1min post-mortem period
in homogenization buffer (5mM sodium phosphate, pH
7.4, 320mM sucrose, 100mM NaF, 500µM PMSF and a
protease inhibitor mixture (2µg/mL aprotinin, 2µg/mL
anti-pain, 1µg/mL leupeptin, and 10µg/mL benzamidine).
Protein concentration was determined by BCA assay
(Pierce/ThermoFisher).
SDS-PAGE and Immunoblots
Cell lysates were prepared from transfected HEK293 cells as
described (Shi et al., 1994; Manganas and Trimmer, 2000). In
brief, cells were lysed for 5min on ice in an ice-cold lysis buffer
solution containing TBS (20mM Tris, 150mM NaCl, pH 8.0),
10mM EDTA, 2% Triton X-100, 10mM iodoacetamide, 10mM
NaF, and a protease inhibitor mixture (2µg/mL aprotinin,
1µg/mL leupeptin, 2µg/mL antipain, 10µg/mL benzamidine,
and 1mM PMSF). The detergent lysate was centrifuged in a
microcentrifuge for 5min at 16,100 × g to pellet nuclei and
debris, and the resulting supernatant (cleared lysate) was saved
for analysis. For immunoblots, crude brain homogenate or MBM
fractions (30 µg protein/lane) or the HEK293 cell cleared lysate
was added to one-third volume of 4X reducing SDS sample
buffer and fractionated on 9% SDS-polyacrylamide gels, and
transferred to nitrocellulose membranes. All subsequent steps
were performed at RT. Immunoblots were blocked in 4% non-
fat dry milk/0.1% Tween-20/TBS, and probed with various
Abs. Primary Abs were detected with mouse IgG subclass-
specific rabbit or goat secondary Abs conjugated to Alexa
Fluors (Molecular Probes/ThermoFisher) using a FluorChem
Q imager (ProteinSimple). Immunoblots were analyzed using
FluorChem software and statistical analysis was performed using
StatPlus or Prism. Note that “lauryl sulfate” (Sigma L-5750; 69%
lauryl sulfate (SDS), 26% myristyl sulfate, 5% cetyl sulfate) was
used in SDS gel recipes to accentuate electrophoretic mobility
differences between different phosphorylation states of Kv2.1 (Shi
et al., 1994; Murakoshi et al., 1997) and Kv2.2 (Bishop et al.,
2015).
Statistics
Prism (GraphPad) software was used to perform statistical tests
on the data obtained from the cortical neurons and HEK cells.
For Manders’ colocalization coefficient (MCC) measurements,
a standard one-way ANOVA with post hoc Sidak’s multiple-
comparison test was used to determine which MCC averages
differed. For Coefficient of Variation (CV) measurements, a
one-way randomized block ANOVA (experiments were treated
as matched sets to account for experiment-to-experiment
variability) with post hoc Sidak’s multiple-comparison test
was used to determine which individual CV means differed
and summary data are presented as across-replicate means
± SEM.
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RESULTS
Anti-AMIGO-1 Antibodies Exhibit Specific
Immunoreactivity in
Immunohistochemistry Assays on Mouse
Brain Samples
A previously published study presented images of
immunofluorescence labeling with a chicken anti-AMIGO-
1 polyclonal antibody in mouse neocortex (Peltola et al.,
2011) that was distinct from that shown in other published
studies (Kuja-Panula et al., 2003; Chen et al., 2012). To
facilitate the characterization of the molecular properties
and localization of AMIGO-1 in brain, we generated anti-
AMIGO-1 rabbit polyclonal and mouse monoclonal antibodies
in house. We validated the specificity of these antibodies for
immunohistochemistry by comparing the signals obtained
in samples prepared from wild-type (WT) and AMIGO-1
knockout (KO) mice. Figure 1 shows exemplar results of these
validation experiments, which show images of somatosensory
cortex from WT and KO mouse brain sections multiplex
labeled with the anti-AMIGO-1 antibodies, and with the
Hoechst 33258 nuclear dye, as an anatomical marker. Each
of these newly generated anti-AMIGO-1 antibodies shows
robust immunolabeling of neurons throughout neocortex in the
samples prepared fromWTmice (Figure 1). However, the strong
AMIGO-1 immunoreactivity seen in WT samples is absent in
the AMIGO-1 KO samples (Figure 1). These results suggest
that the immunolabeling with these newly generated AMIGO-1
antibodies in immunohistochemistry analyses on mouse brain
sections is specific for AMIGO-1, and that AMIGO-1 is primarily
present on the cell bodies and proximal dendrites of neurons.
AMIGO-1 Is Coexpressed and Colocalized
with Kv2.1 and Kv2.2 in Diverse Neuronal
Populations throughout Mouse Brain, and
in Diverse Mammalian Species
A previous study showed extensive overlap of
immunofluorescence signals for AMIGO-1 and Kv2.1 in
mouse neocortex (Peltola et al., 2011). We previously found
extensive overlap of Kv2.1 and AMIGO-1 immunolabeling in
striatal medium spiny neurons (Mandikian et al., 2014). Kv2.1
and Kv2.2 exhibit cell-type specific differences in expression
throughout brain, particularly in neocortical (Kihira et al.,
2010; Bishop et al., 2015) and basal forebrain (Hermanstyne
et al., 2013) neurons. Whether AMIGO-1 is preferentially
colocalized with Kv2.1 or Kv2.2 throughout the brain has not
been determined.
We found that in mouse brain, AMIGO-1 immunolabeling
exhibits extensive overlap with that of both Kv2.1 and Kv2.2
(Figure 2). This is evident in a whole brain sagittal section
(Figure 2A), but also when examining specific brain regions
and neuron classes that express high levels of immunoreactivity
for either Kv2.1, Kv2.2, or for both Kv2 α subunits. For
example, as shown in Figure 2B, in the ventromedial posterior
nucleus of the thalamus (VMPO), Kv2.2 immunolabeling (red)
is substantially stronger than that for Kv2.1 (green) in many
neurons. AMIGO-1 immunolabeling (blue) is strong in neurons
with high levels of Kv2.2, yielding a magenta signal in the
merged image suggesting extensive overlap of red Kv2.2 and
blue AMIGO-1 signals. However, other neurons that have
Kv2.1 and AMIGO-1 immunolabeling exhibit a cyan signal
(indicating overlap of green Kv2.1 and blue AMIGO-1). In
neocortex (Figure 2C), neurons in layer 5A (Figures 2c1–c3),
have prominent immunolabeling for Kv2.1, Kv2.2, and AMIGO-
1, while those in layer 5b (Figures 2c4–c6) have predominantly
Kv2.1 together with AMIGO-1. Lastly, different populations
of neurons in basal forebrain (Figure 2D) exhibit prominent
immunolabeling for either Kv2.1 or Kv2.2; however, both classes
of neurons exhibit prominent AMIGO-1 labeling coclustered
with either Kv2.1 or Kv2.2, with little apparent immunolabeling
signal for AMIGO-1 alone (i.e., pure blue signal in Figure 2).
Therefore, regardless of the levels of clustered Kv2.1 and Kv2.2 in
a particular neuron type, AMIGO-1 is always found extensively
coclustered with one or the other Kv2 α subunit, with no
detectable pools of AMIGO-1 distinct from those present at
the Kv2.1 or Kv2.2 clusters. Immunolabeling performed across
neocortical samples from several species, including rat, ferret,
macaque, and human, revealed that AMIGO-1 immunoreactivity
that colocalizes with one or the other Kv2 α subunit is present in
all of these species (Figure 3). Together, these results demonstrate
strong colocalization of AMIGO-1 with Kv2.1 and/or Kv2.2, and
that this pattern holds across multiple mammalian species.
AMIGO-1 Is Precisely Coclustered with
Both Kv2 α Subunits
Both Kv2.1 and Kv2.2 are present in brain neurons in
large PM clusters (Trimmer, 1991; Scannevin et al., 1996;
Kihira et al., 2010; Bishop et al., 2015) that are found over
neuronal hypolemmal cisternae/ER:PM junctions (Du et al.,
1998; Antonucci et al., 2001; Mandikian et al., 2014; Bishop
et al., 2015; Fox et al., 2015) and apposed to astrocyte
processes (Du et al., 1998). To more precisely determine the
relationship of AMIGO-1 to these unique Kv2 clusters at the
subcellular level, high-resolution immunofluorescence images
were obtained from multiplex-labeled mouse brain sections.
As shown in Figures 4A–C, high-magnification images of
mouse cortical neurons demonstrate that AMIGO-1 precisely
colocalizes with Kv2.1 and Kv2.2, whether the two Kv2 α subunits
are coclustered with one another, or whether they are present
in clusters comprised of primarily one or the other Kv2 α
subunit. Analyses of colocalization using Manders’ colocalization
coefficient (MCC), which measures the co-occurrence of two
signals regardless of their respective intensities (McDonald and
Dunn, 2013) revealed extensive colocalization of AMIGO-1
with both Kv2.1 and Kv2.2 (Figure 4D). In cells from WT
animals, on average 84% and 91% of AMIGO-1 immunosignal
colocalized with Kv2.1 and Kv2.2, respectively. Similarly, in
cells from Kv2.1 KO animals, an average of 77% of AMIGO-
1 immunosignal co-occurred with Kv2.2, while in Kv2.2 KO
animals an average of 85% of AMIGO-1 colocalized with
Kv2.1 immunosignal. Interestingly, significantly more AMIGO-
1 was found to colocalize with Kv2.1 in the Kv2.2 KO than
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FIGURE 1 | Validation of anti-AMIGO-1 antibodies in WT and KO mouse brain. Images of brain sections prepared from WT (Upper) and KO (Lower) mice, and
immunolabeled and imaged under identical conditions. Green = anti-AMIGO-1 immunolabeling. Magenta = Hoechst 33258 nuclear dye. Antibodies used as
indicated. Scale bar = 200µm.
FIGURE 2 | AMIGO-1 expression is highly colocalized with both Kv2.1 and Kv2.2 in mouse brain. (A) Sagittal section of mouse brain immunolabeled for Kv2.1 (green,
K89/34 mAb), Kv2.2 (red, N372B/60 mAb), and AMIGO-1 (blue, L86/33 mAb). Caudate nucleus and putamen, CPU, Neocortex, CTX, Cornu Ammonis areas, CA1-3,
dentate gyrus, DG, dorsal thalamus, dThal. Scale bar = 750µm. (B) Immunolabeling for Kv2.1 (green), Kv2.2 (red), and AMIGO-1 (blue) in a sagittal section of mouse
brain showing strong immunoreactivity of Kv2.2 and AMIGO-1 in cells of the magnocellular preoptic area (MCPO) of the hypothalamus. Scale bar = 20µm. Separate
grayscale images of individual layers for the boxed region are shown to the right. (C) Immunolabeling for Kv2.1 (green), Kv2.2 (red), and AMIGO-1 (blue) in a sagittal
section of mouse brain showing strong immunoreactivity for AMIGO-1 in layer 5 somatosensory cortical neurons that differentially express Kv2.1 and Kv2.2. Scale
bar = 20µm. Separate grayscale images of individual layers are shown to the right for cells in layer 5a (c1,c2,c3) and layer 5b (c4,c5,c6). Scale bar of insets = 10µm.
(D) Immunolabeling for Kv2.1 (green), Kv2.2 (red), and AMIGO-1 (blue) in a sagittal section of mouse brain showing strong immunoreactivity for AMIGO-1 among cells
of the basal forebrain that differentially express Kv2.1 and Kv2.2. Scale bar = 20µm. Note that areas of overlap between the three fluorescent signals appear white.
with Kv2.2 in the Kv2.1 KO (AMIGO-1 in Kv2.2 KO, 85%
vs. AMIGO-1 in Kv2.1 KO, 77%; p < 0.05). Additionally,
significantly more AMIGO-1 was found to colocalize with Kv2.2
in cells from WT animals than in cells from Kv2.1 KO animals
(AMIGO-1 colocalization with Kv2.2 in WT, 91% vs. AMIGO-1
colocalization with Kv2.2 in Kv2.1 KO, 77%; p < 0.001). Analyses
of clustering using coefficient of variation of pixel intensity, a
measure of variability and non-uniformity of fluorescence signals
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FIGURE 3 | AMIGO-1 is coexpressed with Kv2 α subunits in multiple species.
Brain sections from rat, ferret, macaque, and human immunolabeled for Kv2.1
(green, K89/34R mAb), Kv2.2 (red, N372B/1 mAb), and AMIGO-1 (blue,
L86A/37 mAb). Images were adjusted linearly for optimal display. Scale
bars = 100µm.
(Bishop et al., 2015), reveal that the populations of Kv2.1, Kv2.2,
and AMIGO-1 in cortical neurons are present in clusters with
similar characteristics (Figure 4E). These results show that in
adult brain, AMIGO-1 is extensively associated with Kv2 α
subunits, and that no autonomous AMIGO-1 populations with
localizations distinct from that of Kv2.1 or Kv2.2 are apparent.
AMIGO-1 Is Localized Over Hypolemmal
Subsurface Cisternae at the Ultrastructural
Level
We used pre-embedding electron microscopic labeling in
hippocampal CA1 pyramidal neurons to define the localization
of Kv2.1 and AMIGO-1 at the ultrastructural level. As expected
for subunits of a membrane protein, immunogold particles
for Kv2.1 and AMIGO-1 were predominantly PM bound,
and the rarely encountered cytosolic particles were generally
associated with internal membranes. In good agreement with
the cytoplasmic location of the epitopes of the mAbs used here,
PM bound immunogold particles for Kv2.1 and AMIGO-1
were always observed in the vicinity of the inner leaflet of
the PM. Interestingly, the ultrastructural localization pattern
of AMIGO-1 exhibited striking similarities to the previously
reported EM localization pattern of Kv2.1 (Du et al., 1998;
Mandikian et al., 2014) and Kv2.2 (Bishop et al., 2015). In
particular, both Kv2.1 and AMIGO-1 immunogold particles
had a characteristic clustered pattern in the somatodendritic
compartment (Figures 5A–I) and were located at the PM
at sites corresponding to the edges of the juxtaposed
hypolemmal subsurface cisternae (i.e., at ER:PM junctions)
(Figures 5A–C,E–G). The labeling was also observed both
in large (Figure 5H) and small caliber (Figure 5I) dendrites,
presumably representing the apical dendritic shaft and oblique
branches, respectively. Immunogold particles for Kv2.1 and
AMIGO-1 were rarely observed in dendritic spines (data not
shown) and were not detected in myelinated axons (Figure 5E)
and presynaptic boutons. These results show that in adult brain
neurons, AMIGO-1 is predominantly/exclusively present at PM
sites typical of those containing Kv2 α subunits.
Kv2.1 and Kv2.2 Promote Clustering of Cell
Surface AMIGO-1 at ER:PM Junctions in
Heterologous Cells
The lack of autonomous AMIGO-1 populations in mammalian
brain neurons suggests Kv2 α subunits could play a role
in organizing the subcellular localization of AMIGO-1. The
initial report of AMIGO-1:Kv2.1 association showed that when
coexpressed in heterologous HEK293 cells, AMIGO-1, and Kv2.1
exhibit extensive overlap in PM-associated clusters (Peltola
et al., 2011) that are typical for Kv2.1 expressed in this cell
background (Mohapatra and Trimmer, 2006; Kihira et al.,
2010; Bishop et al., 2015). Recent studies have revealed that
Kv2.2 (i.e., Kv2.2L; Kihira et al., 2010) is also clustered
when expressed in HEK293 cells (Kihira et al., 2010; Bishop
et al., 2015). Given the extensive coclustering of AMIGO-
1 and Kv2.2 in certain brain neurons (Figures 2–4) we
next investigated whether AMIGO-1 colocalizes with Kv2.2
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FIGURE 4 | AMIGO-1 coclusters with Kv2.1 and Kv2.2 in neurons.
High-magnification images of layer 5 pyramidal cells from S1 cortex of (A) WT
mice immunolabeled for Kv2.1 (green, K89/34 mAb), Kv2.2 (red, N372B/60
mAb), and AMIGO-1 (blue, L86/33 mAb), and (B) Kv2.1 KO, and (C) Kv2.2 KO
mice immunolabeled for Kv2 (magenta) and AMIGO-1 (green). Images were
adjusted linearly for optimal display. Note that areas of overlap between the
three fluorescent signals in (A), and the two fluorescent signals in
(Continued)
FIGURE 4 | (B,C), appear white. Scale bars = 10µm. (D) Summary graph of
MCC values measured for Kv2.1 (green) and Kv2.2 (red) and AMIGO-1 (blue)
in cortical cells from WT, Kv2.1-KO and Kv2.2-KO animals (n = 16 cells each).
Gray bars connect MCC values for Kv2 and AMIGO-1 from the same neuron.
Error bars denote mean and SEM for each group. Differences in MCC values
were evaluated by one-way ANOVA followed by Sidak’s multiple-comparison
test. ***p = 3.38 × 10−6, *p = 0.0102. (E) Summary graph of CV
measurements of cortical cells from WT, Kv2.1-KO and Kv2.2-KO mice
immunolabeled for Kv2.1, Kv2.2 and AMIGO-1. Error bars represent the SEM
for n = 3 groups. Differences in CV measurements between immunosignals
were evaluated by one-way randomized block ANOVA followed by Sidak’s
multiple-comparison test. The p values for these pairwise comparisons of CV
values were: Kv2.1 vs. Kv2.2 in WT: p = 0.554, Kv2.1 vs. AMIGO-1 in WT:
p = 0.9605, Kv2.2 vs. AMIGO-1 in WT: p = 0.218, Kv2.2 vs. AMIGO-1 in
Kv2.1−/−: p = 0.8672, Kv2.1 vs. AMIGO-1 in Kv2.2−/−: p = 0.9785. Note
that the y-axis origin begins at 0.6.
when coexpressed in heterologous cells. AMIGO-1 was not
clustered when expressed alone, and had a relatively uniform
distribution (Figure 6A). However, we found that in HEK293
cells coexpressing AMIGO-1 with either Kv2.1 or Kv2.2,
AMIGO-1 was present in large clusters that exhibited extensive
overlap with the clustered immunofluorescence signals for these
Kv2 α subunits (Figures 6B–C). Consistent with this, line scans
across HEK293 cells reveal that the fluorescence intensities
for AMIGO-1 (green) exhibit substantial variability, typical
of non-uniform (clustered) localization, in cells coexpressing
Kv2 α subunits (Figure 6J). The AMIGO-1 signals precisely
overlap with those for Kv2 α subunits (magenta) in cells in
which AMIGO-1 is coexpressed with either Kv2.1 or Kv2.2
(Figure 6J). Analysis of the AMIGO-1 immunofluorescence
intensity across many HEK293 cells revealed that the CV of
AMIGO-1 labeling intensity is significantly increased in the
presence of WT Kv2.1 or Kv2.2 (Figure 6K), consistent with
Kv2-induced AMIGO-1 clustering. A significantly increased
incidence of cells with clustered AMIGO-1 was also observed
upon coexpression with either Kv2.1 or Kv2.2 (Figure 6L).
Together these data suggest that association with a clustered Kv2
α subunit induces clustering of otherwise uniformly expressed
AMIGO-1.
To further determine whether these Kv2 α subunits are the
primary determinants of AMIGO-1 clustering, we coexpressed
AMIGO-1 with Kv2 α subunits carrying single Serine to Alanine
point mutations in their clustering domains that eliminate
clustering and yield uniform PM localization (Lim et al., 2000;
Bishop et al., 2015). We found that coexpression of AMIGO-
1 with either the Kv2.1 S586A (Lim et al., 2000) or the Kv2.2
S605A (Bishop et al., 2015) clustering mutants failed to induce
clustering of AMIGO-1 as seen upon coexpression with the WT
Kv2 α subunits (Figures 6D,E,J). The CV of AMIGO-1 labeling
intensity is also not altered in the presence of the non-clustering
Kv2.1 S586A mutant (Figure 6K), although coexpression of
AMIGO-1 with the non-clustering Kv2.2 S605Amutant did yield
a small but significant increase in the CV of AMIGO-1 labeling
intensity, even though distinct AMIGO-1 clusters were not
apparent in these cells (Figure 6K). Consistent with these overall
results, coexpression of AMIGO-1 with the non-clustering Kv2
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FIGURE 5 | Kv2.1 and AMIGO-1 exhibit similar localization pattern at the ultrastructural level. Electron micrographs show the clustered localization of Kv2.1
immunogold particles (arrows) in the soma (A) and dendrite (B,C). A vast majority of immunogold particles are PM associated. Similar to the localization of Kv2.1
shown here, and previous reports on Kv2.1 localization in rat (Du et al., 1998) and mouse (Mandikian et al., 2014), and Kv2.2 localization in mouse (Bishop et al.,
2015), AMIGO-1 immunogold particles also show distinct clustering at the PM of the somata (D–G) and dendrites (H). Immunogold particles are observed both in the
large-caliber apical dendritic shaft (H) and the small-caliber oblique apical dendrites (I). Noteworthy, both Kv2.1 and AMIGO-1 immunogold particles locate to the
edges of subsurface cisternae (arrowheads in A–C for Kv2.1 and F–G for AMIGO). Note the lack of AMIGO-1 immunogold particles in myelinated axon and dendritic
spines. c, cytoplasm; d, dendritic shaft; m, myelinated axon, n, nucleus, s, dendritic spine. Scale bars: 500 nm.
mutants lead to a reduction in the incidence of cells with
clustered AMIGO-1 compared to WT (Figure 6L). We found
that although AMIGO-1 clustering was induced by coexpression
with either Kv2.1 or Kv2.2, coexpression with AMIGO-1 did
not affect the subcellular localization of WT or mutant Kv2.1
or Kv2.2 (Figures 6F–I). These results together suggest that
AMIGO-1 is not competent to form clusters on its own, that Kv2
α subunits are the primary determinants of AMIGO-1 clustering,
and that AMIGO-1 coexpression does not significantly impact
the clustering of coexpressed Kv2 α subunits.
In brain neurons, Kv2.1 and AMIGO-1 are localized in
the PM over hypolemmal subsurface cisternae (Figure 5). In
certain neurons Kv2.1 is found localized over clustered ryanodine
receptors (Antonucci et al., 2001; Mandikian et al., 2014),
and overexpression of Kv2.1 in cultured hippocampal neurons
enhances clustering of ryanodine receptors at sites of Kv2.1
clustering (Antonucci et al., 2001). Recent studies revealed that
exogenous Kv2.1 expression can recruit/stabilize ER at the PM,
and enhance ER:PM junctions, in heterologous cells and neurons
(Cobb et al., 2015; Fox et al., 2015). Given the apparent presence
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FIGURE 6 | Kv2 α subunits promote clustering of AMIGO-1. HEK293 cells expressing (A) AMIGO-1 (green) alone, (B) AMIGO-1 (green) and Kv2.1 (magenta),
(C) AMIGO-1 (green) and Kv2.2 (magenta), (D) AMIGO-1 (green) and S586A (magenta), and (E) AMIGO-1 (green) and S605A (magenta). Images were adjusted linearly
for optimal display. Scale bar = 10µm. HEK293 cells expressing (F) Kv2.1, (G) Kv2.2, (H) S586A, and (I) S605A alone. (J) AMIGO-1 (green) and Kv2 (magenta)
fluorescence intensity values across individual line scans depicted by the white lines in the AMIGO-1 image in (A), and the merged images in (B–E). Note that areas of
overlap between the two fluorescent signals appear white. (K) Coefficient of variation (CV) of AMIGO-1 fluorescence intensity in HEK293 cells expressing AMIGO-1
with the indicated Kv2 α subunit, relative to AMIGO-1 alone. Values are normalized to control. Data are the mean ± SEM from n = 4 independent samples of at least
14 cells each. The p values for these pairwise comparisons of CV values vs. cells expressing AMIGO-1 alone are: AMIGO-1 + Kv2.1: 0.0270, AMIGO-1 + S586A:
(Continued)
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FIGURE 6 | 0.5366, AMIGO-1 + Kv2.2: 0.0167, AMIGO-1 + S605A: 0.0066. (L) HEK293 cells coexpressing AMIGO-1 with the indicated Kv2 α subunit were scored
as having either clustered or unclustered AMIGO-1. Cells with over 25% of their membrane covered in clusters were considered clustered. Data are from an n = 4
independent samples of at least 100 cells each. The p values for these pairwise comparisons of clustering vs. cells expressing AMIGO-1 alone are: AMIGO-1 + Kv2.1:
2.345 × 10−6, AMIGO-1 + Kv2.2: 3.909 × 10−6, AMIGO-1 + S586A: 0.0004, AMIGO-1 + S605A: 0.4584. For other pairwise comparisons of clustering: AMIGO-1
+ Kv2.1 vs. AMIGO-1 + S586A: p = 0.0011, AMIGO-1 + Kv2.2 vs. AMIGO-1 + S605A: p = 0.0010.
of AMIGO-1 in many native Kv2.1 complexes, we next addressed
whether Kv2.1:AMIGO-1 complexes could recruit/stabilize ER
as occurs upon exogenous expression of Kv2.1 alone (Cobb
et al., 2015; Fox et al., 2015). We coexpressed DsRed-tagged
Kv2.1, YFP-tagged AMIGO-1 and BFP-tagged SEC61β (a general
ER marker) in HEK293 cells and performed live cell TIRF
imaging to selectively visualize PM and near PM ER (i.e.,
ER:PM junctions). We found that similar to the results obtained
using immunocytochemistry on fixed cells (Figure 6), in live
cells the cell surface Kv2.1 and AMIGO-1 precisely colocalized
with one another (Figure 7A), as shown by their high PCC
values (0.90 ± 0.065, n = 16 cells; Figure 7F). The uniformly
expressed PM AMIGO-1 signal in cells expressing AMIGO-1
alone (Figure 7C) was not colocalized with the reticular/tubular
ER signal (Figure 7C′) (PCC values 0.39 ± 0.14, n = 16 cells).
However, when coexpressed with Kv2.1, AMIGO-1 exhibited
prominent colocalization with the resultant ER:PM junctions
(Figure 7E), with PCC values (0.90 ± 0.037, n = 16 cells)
significantly higher (p = 1.62 × 10−14) than in cells expressing
AMIGO-1 alone (Figure 7F). Kv2.1 expressed alone colocalized
with associated ER:PM junctions (Figure 7D), and had PCC
values (0.90 ± 0.041, n = 16 cells; Figure 7F) not significantly
different (p = 0.4798) than those in cells coexpressing Kv2.1 and
AMIGO-1 (Figure 7E) (0.88 ± 0.070, n = 16 cells; Figure 7F).
Moreover, the mean size of ER:PM junctions on a per cell basis
were significantly increased (Figure 7G) by expression of Kv2.1
alone (Figure 7D′; mean ER:PM junction size 1.00 ± 0.32 µm2,
n = 9 cells, p = 5.275 × 10−5 vs. untransfected cells), and by
coexpression of Kv2.1 and AMIGO-1 (Figure 7E′; mean ER:PM
junction size 1.28 ± 0.60 µm2, n = 9 cells, p = 6.463 × 10−4
vs. untransfected cells), but not by expression of AMIGO-1 alone
(Figure 7C′; mean ER:PM junction size 0.33± 0.092 µm2, n= 9
cells, p = 0.3119 vs. untransfected cells, mean ER:PM junction
size 0.38± 0.12 µm2, n= 9 cells). An untransfected cell example
is shown in Figure 7B. These results show that when expressed
alone in heterologous cells, AMIGO-1 is not present at ER:PM
junctions, but when coexpressed with Kv2.1 the Kv2.1:AMIGO-
1 complexes exist at the enhanced ER:PM junctions present in
cells expressing Kv2.1. It also illustrates that the Kv2.1:AMIGO-
1 complexes can recruit/stabilize ER at these sites, but that
AMIGO-1 can neither recruit/stabilize these junctions on its
own, nor influence the ability of Kv2.1 to impact these junctions.
AMIGO-1 Localization in Brain Neurons Is
Impacted by Genetic Ablation of Kv2 α
Subunit Expression
Given the results above that demonstrate extensive coexpression
and colocalization of AMIGO-1 with Kv2.1 and Kv2.2 in
mammalian brain neurons, and the requirement for Kv2 α
subunit coexpression for clustering of AMIGO-1 at ER:PM
junctions in heterologous cells, we next determined how ablation
of expression of Kv2 α subunits in KO mice would impact the
clustered subcellular localization of AMIGO-1 at specific sites in
brain neurons in vivo. Figure 8A shows labeling for Kv2.1 (green)
and Kv2.2 (red), in conjunction with AMIGO-1 labeling (blue)
in mouse brain sagittal sections prepared from WT, Kv2.1 KO
and Kv2.2 KO mice. As is apparent in both the Kv2.1 KO and
the Kv2.2 KO sections, while AMIGO-1 signal is still present, it
is only retained in the neurons that express the remaining Kv2
α subunit, and is absent in neurons in which expression of the
predominant Kv2 α subunit was eliminated in the KO. This is
especially clear in neocortex, as unlike the widespread expression
of Kv2.1, Kv2.2 expression is limited primarily to cortical layers 2
and 5a (Bishop et al., 2015). Following genetic ablation of Kv2.1
expression, AMIGO-1 labeling in neocortex is now restricted
to these specific layers, and is lost in the other neocortical
layers that would normally express high levels of Kv2.1
(Figure 8A).
The restricted cellular expression of AMIGO-1 in the Kv2.1
KO in only those neurons with robust Kv2.2 expression
suggests that maintenance of AMIGO-1 may require expression
of a Kv2 α subunit. To determine if this is the case, we
generated homozygous Kv2.1/Kv2.2 double knockout mice (Kv2
dKO) by crossing Kv2.1 heterozygotes (Kv2.1+/−) to Kv2.2
homozygous KO mice (Kv2.2−/−). Importantly, the gross brain
morphology is maintained in the Kv2 dKO (data not shown),
and immunolabeling with the neocortical layer markers Cux1
(L2-4), Satb2 (L2-6), and Ctip2 (L5b-6) revealed no gross
abnormalities in neocortical layering or cell density in the
dKO mouse brain samples compared to those from WT mice
(Figure 8B). However, no clear AMIGO-1 immunolabeling
signal was apparent in the Kv2 dKO samples (Figure 8A). Similar
results were obtained using multiple Abs against AMIGO-1
(data not shown), including two different mouse mAbs with
distinct cytoplasmic domain binding sites (L86/33 and L86A/37),
and a rabbit pAb (AMIGO-1) made against the intracellular
C-terminus, as well as a mouse mAb (L98/12) directed against
the extracellular N-terminus, suggesting that this is not likely
due to a mere change in AMIGO-1 immunoreactivity, but
to decreased AMIGO-1 expression. These results suggest that
AMIGO-1 expression is substantially reduced in the absence of
Kv2 α subunit expression in adult brain neurons in vivo.
Kv2.1 and Kv2.2 Promote AMIGO-1 Cell
Surface Expression in Heterologous Cells
Given the substantial loss of AMIGO-1 immunolabeling in
brain sections upon elimination of Kv2 α subunit expression
in vivo, we next examined how Kv2 α subunits influence
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FIGURE 7 | Kv2.1:AMIGO-1 complexes are present at and recruit/stabilize
ER:PM junctions. Live cell TIRF imaging. (A) Cell expressing YFP-AMIGO-1
(green) and DsRed-Kv2.1 (red). (B) Untransfected cell showing ER (SEC61β)
labeling. (C) Cell expressing YFP-AMIGO-1 (green) showing ER (SEC61β, blue)
labeling. (C′) ER (SEC61β) labeling of cell in (C). (D): Cell expressing
DsRed-Kv2.1 (red) showing ER (SEC61β, blue) labeling. (D′): ER (SEC61β)
labeling of cell in (D). (E) Cell expressing YFP-AMIGO-1 (green) and
DsRed-Kv2.1 (red) showing ER (SEC61β, blue) labeling. (E′) ER (SEC61β)
labeling of cell in panel E. Note that areas of overlap between the three
fluorescent signals appear white. Scale bar = 10µm. (F) Graph of Pearson’s
Colocalization Coefficient (PCC) values for SEC61β and AMIGO-1 (filled
circles), or SEC61β and Kv2.1 (open circles). Partially filled circles are PCC
values for AMIGO-1 and Kv2.1. Bars are the mean ± SEM. ****p = 1.62 ×
10−14. ns: p = 0.4798. (G) Mean ER:PM junction size (in µm2 ) for cells
expressing SEC61β ER marker alone, or with AMIGO-1 and/or Kv2.1 as
indicated. Bars are the mean ± SEM. ns: p = 0.3119. ****p = 5.275 × 10−5.
***p = 6.463 × 10−4.
AMIGO-1 expression in heterologous cells. Immunolabeling
of cell surface AMIGO-1 in intact cells expressing AMIGO-1
alone using a mAb (L98/12) targeting an extracellular region
of AMIGO-1 revealed uniform diffuse PM-associated labeling
(Figure 9). Immunolabeling of total AMIGO-1 in permeabilized
cells revealed a substantial intracellular AMIGO-1 population
(Figure 9). The level of cell surface AMIGO-1 increased,
and the level of the intracellular AMIGO-1 decreased, upon
coexpression with Kv2 α subunits, indicating a redistribution
of the intracellular AMIGO-1 population to the cell surface
(Figure 9). The enhancement of the cell surface AMIGO-1
population was observed upon coexpression of AMIGO-1 with
both the clustered WT Kv2 α subunits, as well as with the
non-clustered Kv2.1 S586A and Kv2.2 S605A point mutants
(Figure 9). This indicates that the ability of Kv2 α subunits to
enhance AMIGO-1 cell surface expression is independent of
formation of PM clusters.
FIGURE 8 | Mice lacking Kv2 α subunits have altered AMIGO-1 expression.
(A) Mouse sagittal brain sections from WT, Kv2.1 KO, Kv2.2 KO, and Kv2 dKO
mice immunolabeled for AMIGO-1 (blue, AMIGO-1 pAb), Kv2.2 (red,
N372B/60 mAb), and Kv2.1 (green, K89/34 mAb). Note the lack of AMIGO-1
labeling present in the Kv2 double KO mice. Scale bar = 100µm. (B) Sagittal
brain sections from WT and Kv2 dKO mice immunolabeled for cortical layer
markers Cux1 (red), Satb2 (blue), and Ctip2 (green). Cortices of dKO mice
show no gross abnormalities in cortical laminae or cell density. Scale
bar = 100µm. Note that areas of overlap between the three fluorescent
signals appear white.
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FIGURE 9 | Kv2 α subunits increase AMIGO-1 cell surface localization in heterologous cells. HEK293 cells expressing AMIGO-1 alone, or AMIGO-1 plus WT Kv2.1 or
Kv2.2, or the respective clustering deficient mutants Kv2.1 S586A or Kv2.2 S605A, as indicated. Cells were immunolabeled for total AMIGO-1 (green) and cell surface
AMIGO-1 (magenta). All images within the left and right panels were acquired under identical conditions and were linearly adjusted identically. Note that areas of
overlap between the two fluorescent signals appear white. Scale bar = 10µm. The graph shows the ratio of cell surface: total AMIGO-1 fluorescence intensity
measured in HEK293 cells expressing AMIGO-1 alone or with the indicated Kv2 α subunits. Values are normalized to cells expressing AMIGO- alone. Data are the
mean ± SEM from 4 independent samples of at least n = 67 cells total. The p values (two-tailed unpaired t-test) for surface/total AMIGO-1 levels relative to AMIGO-1
alone: AMIGO-1 + Kv2.1: 2.192 × 10−37, AMIGO-1 + S586A: 4.681 × 10−20, AMIGO-1 + Kv2.2: 8.240 × 10−13, AMIGO-1 alone vs. AMIGO-1 + S605A: 9.921 ×
10−17.
We next used immunoblots to further characterize the cell
surface and intracellular populations of AMIGO-1 expressed in
heterologous cells, without and with Kv2 α subunit coexpression.
Immunoblotting for AMIGO-1 reveals two populations with
distinct electrophoretic mobility, one of Mr ≈ 76 kD, and one
of Mr ≈ 66 kD (Figure 10A). These electrophoretically distinct
AMIGO-1 populations arise from distinct posttranslational
processing of N-linked sugar chains on the AMIGO-1
glycoprotein (Kajander et al., 2011), presumably reflecting
distinct locations within the cell. To confirm this, we employed
an assay in which live cells are treated with the membrane
impermeant protease Proteinase K to selectively digest the
extracellular domains of PM localized proteins (Zhou et al.,
1998; Manganas and Trimmer, 2000). We found that the Mr
≈ 76 kD AMIGO-1 population was selectively eliminated by
Proteinase K treatment, while the levels of the Mr ≈ 66 kD
population remained unaffected (Figure 10B). This supports
that the Mr ≈ 76 kD population corresponds to cell surface
AMIGO-1, while the Mr ≈ 66 kD population corresponds
to intracellular AMIGO-1. We next assessed whether Kv2 α
subunit coexpression alters the cell surface expression levels
of AMIGO-1 by immunoblotting samples from HEK293 cells
expressing AMIGO-1 alone or coexpressing Kv2 α subunits. A
significant increase in the cell surface (Mr ≈76 kD) AMIGO-1
population was seen upon coexpression of either Kv2.1 or
Kv2.2 (Figure 10A). We also observed an increase in the
ratio of the cell surface (Mr ≈76 kD) vs. total (Mr ≈ 76 kD
+ Mr ≈ 66 kD) AMIGO-1 populations (Figure 10C). This
further demonstrates that coexpression with either Kv2.1 or
Kv2.2 facilitates intracellular trafficking of AMIGO-1 and
promotes a redistribution of intracellular AMIGO-1 to the cell
surface.
The Expression Level and Posttranslational
Processing of AMIGO-1 in Adult Brain Is
Impacted by Loss of Kv2 α Subunit
Expression
Our immunohistochemical results suggest that the expression
levels of AMIGO-1 are strikingly reduced in the brains of
Kv2 dKO mice. We performed immunoblot analyses on WT,
Kv2.1 KO, Kv2.2 KO, and Kv2 dKO whole brain homogenates,
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and confirmed that the individual Kv2 α subunits were
absent in their respective KO samples, and in the Kv2 dKO
samples. Largely consistent with the immunohistochemistry
results above (Figure 8), the overall levels and characteristics of
the population of AMIGO-1 detected with a mAb against the
intracellular C-terminus were largely maintained in the Kv2.2
KO (Figures 11A,B). However, the overall levels of AMIGO-1
were significantly reduced in samples from the Kv2.1 KO mice,
and from the Kv2 dKO mice (Figures 11A,B). Notably, in the
samples from the Kv2 dKO mice, the levels of the Mr ≈ 76 kD
cell surface population of AMIGO-1 were significantly reduced
compared to samples from WT mice (Figure 11A). As such, a
higher proportion of the AMIGO-1 signal in both the Kv2.1
KO and the Kv2 dKO homogenates was present in the lower
Mr population than in the WT or Kv2.2 KO samples. These
results suggest both an overall decrease in AMIGO-1 expression
FIGURE 10 | Kv2 α subunits increase cell surface expression of AMIGO-1.
(A) Representative immunoblot of HEK293 cell lysates expressing AMIGO-1,
AMIGO-1 + Kv2.1, AMIGO-1 + Kv2.2, Kv2.1, or Kv2.2. Numbers to the left of
immunoblots indicate the mobility of molecular mass standards in kD. See
Figure S1 for original immunoblot. (B) Representative immunoblot of
AMIGO-1 expressing HEK293 cells treated with or without proteinase K (PK).
Numbers to the left of the immunoblots indicate the mobility of molecular mass
standards in kD. See Figure S2 for original immunoblot. (C) The ratio of the
intensity of AMIGO-1 cell surface (top band) to total (sum of top and bottom
bands) was measured in HEK293 cells expressing AMIGO-1 alone (control),
AMIGO-1 with Kv2.1 (white bar), or AMIGO-1 with Kv2.2 (black bar). Values
are normalized to control. Data are the mean ± SEM from n = 4 independent
samples. The p (two-tailed unpaired t-test) for surface/total AMIGO-1 levels
relative to AMIGO-1 alone: AMIGO-1 + Kv2.1: 0.0003, AMIGO-1 + Kv2.2:
2.6111 × 10−5.
levels, as well as reduced PM trafficking, as evidenced by
reduced levels of the higher Mr ≈76 kD cell surface population,
and that the remaining AMIGO-1 is present in the lower Mr
intracellular populations. Taken together, these results suggest
that Kv2 expression is necessary for the proper expression and
cell surface localization of AMIGO-1 in adult brain neurons
in vivo.
DISCUSSION
Here we show that AMIGO-1 extensively colocalizes with both
Kv2.1 and Kv2.2 in neurons throughout the brain in diverse
mammalian species. In fact, there is no apparent AMIGO-1
population outside of that colocalized with Kv2 α subunits that
would suggest a role for AMIGO-1 in adult brain outside of being
an auxiliary subunit of Kv2 channels. Moreover, the presence
of one or another Kv2 α subunit is needed to maintain overall
expression and localization of AMIGO-1 in adult brain neurons.
The expression and localization of AMIGO-1 reported
herein are generally consistent with more limited published
immunohistochemical analyses of AMIGO-1, which
demonstrated colocalization of AMIGO-1 and Kv2.1 in adult
mouse neocortex (Peltola et al., 2011) and striatum (Mandikian
et al., 2014). These studies, and the results presented here,
FIGURE 11 | AMIGO-1 cell surface expression is preferentially decreased in
mice lacking Kv2 α subunits. (A) Representative immunoblot of crude whole
brain homogenates from WT, Kv2.1 KO, Kv2.2 KO, and Kv2 double KO mice.
Immunoblots were probed with mAbs against Kv2.1 (K89/34 mAb), Kv2.2
(N372B/60 mAb), AMIGO-1 (AMIGO-1 pAb), and Grp75 (N52A/42 mAb) as a
loading control. Note that AMIGO-1 signal in higher Mr bands is substantially
reduced in both Kv2.1 KO and Kv2 dKO as compared to WT. Numbers to the
left of the immunoblots indicate the mobility of molecular mass standards in
kD. The asterisk to left of the AMIGO-1 panel shows approximate location
AMIGO-1 population of Mr = 66 kD. See Figure S3 for original immunoblot.
(B) Summary graph of differences in AMIGO-1 protein levels between WT and
KO mice. Fluorescence intensity values were normalized to the loading control
(Grp75) and then expressed relative to the total WT signal. Data are the mean
± SEM from n = 4 mice per group. Differences in AMIGO-1 expression
between WT and Kv2.1 KO as well as WT and Kv2 dKO were statistically
significant as evaluated by independent t-test (Kv2.1 KO, p = 0.002; Kv2.2
KO, p = 0.36; Kv2 dKO, p = 0.004).
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suggest a cellular and subcellular localization of AMIGO-1 on
the cell bodies and proximal dendrites of diverse populations of
neurons throughout the brain. However, the overall pattern of
AMIGO-1 localization shown here is distinct from that shown
in the original study of AMIGO-1 expression and localization
in rat (Kuja-Panula et al., 2003), and mouse (Chen et al., 2012)
brain, which used anti-AMIGO-1 antibodies distinct from one
another, and distinct from those used here. The basis for the
distinct immunolabeling patterns obtained with these different
anti-AMIGO-1 Abs is not known. The results presented here,
obtained using a diverse panel of KO-validated monoclonal and
polyclonal anti-AMIGO-1 Abs with distinct binding sites on
AMIGO-1, in general yielded a pattern of localization consistent
with that reported for mouse neocortex in a recent study (Peltola
et al., 2011). We note that in addition to its presence on the
soma and proximal dendrites of adult brain neurons, AMIGO-1
immunolabeling is also present on the axon initial segment
(Bishop and Trimmer, unpublished data), the other major site
of Kv2 channel expression (Johnston et al., 2008; Sarmiere et al.,
2008; Sánchez-Ponce et al., 2012; King et al., 2014).
The clustered localization of AMIGO-1 on the soma and
proximal dendrites of adult brain neurons is interesting
in light of the role of AMIGO-1 during development as
an adhesion molecule involved in development of neuronal
circuitry. Knockdown of AMIGO-1 expression in developing
zebrafish impairs the formation of fasciculated fiber tracts and
disturbs the development of dopaminergic circuits (Zhao et al.,
2014). However there are no gross anatomical abnormalities in
the brains of constitutive global AMIGO-1 KO mice (Peltola
et al., 2016), or, as shown here, in Kv2 dKO mice, which also
have greatly reduced levels of AMIGO-1 expression, particularly
in the neuronal PM. Future studies investigating the expression
and localization of AMIGO-1 during development in WT and
Kv2 KO mice may shed light on whether AMIGO-1 plays a
distinct role as a cell adhesion protein promoting axon growth
and fasciculation (Kuja-Panula et al., 2003) and/or dendritic
outgrowth (Chen et al., 2012) during early mouse development,
and how this role is impacted by Kv2 α subunits.
We found that expression and trafficking of AMIGO-1
in adult mouse brain and in heterologous cells is enhanced
by Kv2 α subunits. It is interesting that manipulating the
expression of one or the other Kv2 α subunit so profoundly
alters the overall expression level and subcellular localization
of AMIGO-1, yet has little impact on the expression of the
remaining Kv2 α subunit paralog [also see (Speca et al., 2014;
Bishop et al., 2015)]. That this phenomenon was observed
using distinct immunohistochemical and biochemical assays
employing multiple anti-AMIGO-1 and Kv2 Abs with distinct
binding sites is supportive that these changes in AMIGO-1
immunolabeling reflect changes in AMIGO-1 protein expression
itself, as opposed to changes in AMIGO-1 immunoreactivity.
Based on our heterologous cell results, we speculate that
inefficient trafficking and intracellular retention of AMIGO-1,
leading to enhanced degradation, results in the reduced levels of
AMIGO-1 seen in adult brain neurons lacking Kv2 α subunits.
A similar loss of auxiliary subunit expression upon elimination
of partner principal subunits was previously observed for the
cytoplasmic KChIP auxiliary subunits of Kv4 channels (Menegola
and Trimmer, 2006), whose stability is reduced in the absence of
their partner Kv4 α subunit (Foeger et al., 2010). Whether Kv2
channel expression is similarly required to support the function
of AMIGO-1 as homophilic cell adhesion molecule underlying
neurite outgrowth and fasciculation during development (Kuja-
Panula et al., 2003; Chen et al., 2012) is not known.
We note that the almost complete loss of AMIGO-1
immunolabeling signal in the Kv2 dKO brain sections in
our immunohistochemistry experiments (Figure 8) is more
substantial than that observed in our biochemical experiments
(Figure 11). Our immunoblot data suggest that the bulk of the
AMIGO-1 retained intracellularly in dKO neurons is within
(and likely throughout) the ER, as modifications to the N-linked
glycans on AMIGO-1 that typically occur in the Golgi apparatus
and yield altered electrophoretic mobility are lacking in the
samples from the dKO mice. It is plausible that the loss of
AMIGO-1 immunolabeling intensity in brain sections is due to a
dilution effect when comparing the highly clustered AMIGO-1 in
the PM to that retained in and distributed throughout the ER.We
calculate, using a sphere with diameter of 20µm to approximate
a neocortical neuron cell body, that intracellular/ER retention
would result in an ≈60-fold reduction in maximum signal
intensity relative to the same amount of protein concentrated in
the PM (representing ≈0.15% of the cell volume), vs. the 10%
of cellular volume typically ascribed to the ER (Alberts et al.,
2014). The further concentration of AMIGO-1 in high density
clusters, which we estimate comprise <20% of the PM area of
a neocortical cell body, would further contribute to the robust
AMIGO-1 immunolabeling signal from PM clustered AMIGO-
1 as present in sections from WT mice relative to signal from
predominantly intracellular AMIGO-1 present in dKO mouse
sections.
The relative impact of eliminating expression of Kv2.1 and
Kv2.2 in the single and double KOs on the expression levels of
AMIGO-1 may also provide valuable insights into the relative
expression levels of these Kv2 α subunits, information not
available from Kv2.1- and Kv2.2-specific immunolabeling. If we
make the assumptions that AMIGO-1 is present at the same
stoichiometry in all Kv2-containing channels, regardless of the
proportion of Kv2.1 vs. Kv2.2 in these complexes, and that
AMIGO-1 expression is similarly impacted by loss of Kv2.1
and Kv2.2. we can then use the relative impact of elimination
of these Kv2 α subunits to estimate the relative expression
levels of Kv2.1 and Kv2.2 in brain. As shown in Figure 11,
elimination of Kv2.1 expression yields a larger (46%) reduction
in AMIGO-1 expression than does elimination of Kv2.2 (9%
reduction), suggesting that in mouse brain Kv2.1 may be ≈5X as
abundant as Kv2.2. Note that while there are many caveats to this
admittedly simple analysis, such differences in overall expression
levels might contribute to the more robust overall behavioral
phenotype observed in Kv2.1 KOmice (Speca et al., 2014) relative
to more subtle behavioral phenotype reported for Kv2.2 KOmice
(Hermanstyne et al., 2013).
We found that AMIGO-1 colocalizes with both Kv2.1 and
Kv2.2 inmammalian brain neurons and inHEK293 cells, and that
coexpression with either Kv2 α subunit is necessary for efficient
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cell surface expression and clustering of AMIGO-1. While
Kv2 α subunits are required for the clustered somatodendritic
localization of AMIGO-1 seen in brain neurons, AMIGO-1 does
not reciprocally impact Kv2 α subunit clustering, as supported
by our studies in heterologous cells, and by a recent report that
showed that while a reduction in overall Kv2.1 expression levels
was seen in AMIGO-1 KO mice, the remaining Kv2.1 remained
localized in PM clusters on neuronal somata and proximal
dendrites (Peltola et al., 2016). Our immuno-electronmicroscopy
results show that AMIGO-1 is localized in the PM near the edges
of the hypolemmal subsurface cisternae, similar to what has been
previously demonstrated for Kv2.1 (Du et al., 1998; Mandikian
et al., 2014) and Kv2.2 (Bishop et al., 2015), and our live cell
imaging studies show that AMIGO-1:Kv2 complexes can recruit
ER to ER:PM junctions. Interestingly, Kv2.1 alone also induces
formation of ER:PM junctions (Antonucci et al., 2001; Cobb et al.,
2015; Fox et al., 2015). Kv2.1 clusters in the PM of brain neurons
are also closely opposed to astrocytic processes (Du et al., 1998),
possibly to allow rapid removal of K+ from the extracellular
space after K+ efflux through Kv2.1 channels. Moreover, Kv2.1
is functionally regulated by extrasynaptic glutamate (Misonou
et al., 2008; Mulholland et al., 2008), whose levels are regulated
in part by astrocyte glutamate uptake. The membrane topologies
of Kv2 α subunits and AMIGO-1 are quite complementary,
in that the extracellular domains of Kv2.1 and Kv2.2 are
very limited compared their extensive cytoplasmic C- and
N-terminal domains (comprising three-fourths of their entire
primary structure), and which contain signals for clustering,
and association with ER:PM junctions, while AMIGO-1 has
a relatively small cytoplasmic C-terminal domain, and a large
extracellular domain. It is interesting to speculate that the
cell adhesion functions of AMIGO-1 may mediate the specific
association of astrocyte processes with sites of neuronal Kv2
channel clustering (Du et al., 1998).
It is clear from our studies here that both in brain neurons
in vivo, and in heterologous cells, AMIGO-1 clustering at sites
overlaying intracellular hypolemmal subsurface cisternae and
apposed to extracellular astrocytic processes requires Kv2 α
subunit coexpression, consistent with the presence of an intrinsic
clustering motif on Kv2.1 and Kv2.2 (Scannevin et al., 1996; Lim
et al., 2000; Mohapatra and Trimmer, 2006; Bishop et al., 2015).
It is intriguing that the Kv2.1 and Kv2.2 α subunit clustering
mutants are still able to promote AMIGO-1 trafficking to the PM,
and to enhance AMIGO-1 posttranslational processing, showing
that clustering per se is not involved in the association of Kv2 α
subunits and AMIGO-1, or in the Kv2-mediated enhancement
of the PM trafficking of AMIGO-1. Structural information on
the Kv2:AMIGO-1 complex itself will shed light on the details of
their interaction, howAMIGO-1 influences Kv2 channel function
and how Kv2 association profoundly impacts the expression and
trafficking of AMIGO-1, as well as its function as a cell adhesion
molecule.
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Figure S1 | Original immunoblot used as the source for the representative
immunoblots shown in Figure 10A. Representative immunoblot of HEK293 cell
lysates expressing AMIGO-1, AMIGO-1 + Kv2.1, AMIGO-1 + Kv2.2, Kv2.1, or
Kv2.2. The leftmost lane is prestained molecular weight standards, only some of
which show up in fluorescence. The respective expression patterns and the colors
of the immunosignals are depicted in the label.
Figure S2 | Original immunoblot used as the source for the representative
immunoblot shown in Figure 10B. Representative immunoblot of AMIGO-1
expressing HEK293 cells treated with or without proteinase K (PK). The leftmost
lane is prestained molecular weight standards, only some of which show up in
fluorescence. The label depicts presence/absence of PK.
Figure S3 | Original immunoblot used as the source for the representative
immunoblot shown in Figure 11A. Representative immunoblot of crude whole
brain homogenates from WT, Kv2.1 KO, Kv2.2 KO, and Kv2 double KO mice.
Immunoblots were probed with mAbs against Kv2.1 (K89/34 mAb, green), Kv2.2
(N372B/60 mAb, red), AMIGO-1 (AMIGO-1 pAb, red), and Grp75 (N52A/42 mAb,
green) as a loading control. The leftmost lane is prestained molecular weight
standards, only some of which show up in fluorescence.
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